Jarl Ulf Jungnelius, a clinical oncologist and industry veteran, has been appointed to the newly created position of chief medical officer at VAXIMM AG, a Swiss-German company developing oral T cell immunotherapies. Dr Jungnelius is a former Celgene Corp executive where he oversaw the clinical research and development of several cancer programmes. Prior to this, he worked at both Pfizer Inc and Eli Lilly and Company. Before joining the industry, Dr Jungnelius was a clinical oncologist at the Karolinska Hospital in Stockholm, Sweden.
VAXIMM announced the appointment on 18 May 2016.
Copyright 2016 Evernow Publishing Ltd